Provectus Biopharmaceuticals PVCT Income Statement (2010-2026)

OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Provectus Biopharmaceuticals Quarterly Income Statement

Periods 64 quarters
Latest Jun 2026

Provectus Biopharmaceuticals reported revenue of -$0.05M and net income of -$0.99M for the quarter ended Jun 2026, down 118.1% year over year. This income statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
-0.45M0.00M-0.02M0.19M0.32M0.31M0.16M0.21M0.16M0.07M0.12M0.24M0.25M0.11M0.01M0.28M0.06M-0.05M
Operating items
Amortization - Intangibles
Depreciation & Amortization - TotalDep. & Amort. (Tot)
466.00466.00465.00
Research & DevelopmentR&D
0.60M0.61M0.74M0.67M0.82M0.58M0.32M0.55M0.43M0.35M0.42M0.56M0.47M0.41M0.61M0.39M0.88M0.35M0.27M0.13M
Selling, General & AdministrativeSG&A
0.62M0.44M0.48M0.52M0.58M0.40M0.53M0.44M0.53M0.43M0.31M0.13M0.58M0.65M1.74M0.99M0.98M0.93M0.85M0.81M
Other Operating ExpensesOther Opex
0.03M0.01M0.02M0.03M0.09M0.01M0.04M
Operating ExpensesOpex
1.22M1.05M1.22M1.19M1.40M0.98M0.85M0.99M0.96M0.78M0.73M0.69M1.05M1.07M2.35M1.38M1.86M1.28M1.12M0.94M
Operating IncomeOp. Inc
-1.22M-1.05M-1.22M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.96M-2.33M-1.10M-1.80M-1.28M-1.12M-0.94M
EBIT
-1.22M-1.05M-1.22M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.96M-2.33M-1.10M-1.80M-1.28M-1.12M-0.94M
Non-operating items
Non Operating Interest Expenses
0.45M0.00M0.02M0.05M0.05M
Interest & Investment IncomeInt & Inv Inc
1.002.00
Other Non Operating IncomeOther Non Op Inc.
0.06M48.00
Non Operating IncomeNon Op. Inc.
-0.36M0.00M-0.02M-0.03M139.00-0.05M-0.05M-0.05M-0.03M-0.06M-0.06M-0.06M-0.05M-0.06M-0.06M-0.05M-0.05M-0.05M-0.05M
Net income details
EBT
-1.67M-1.05M-1.24M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.96M-2.33M-1.10M-1.85M-1.28M-1.12M-0.99M
Profit After TaxPAT
-1.67M-1.05M-1.24M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.96M-2.33M-1.10M-1.85M-1.28M-1.12M-0.99M
Income from Non-Controlling InterestsInc. Minority
-0.02M-0.04M-0.01M0.00M-0.01M
Income from Continuing OperationsIncome (Continuing)
-1.67M-1.05M-1.24M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.96M-2.33M-1.10M-1.85M-1.28M-1.12M-0.99M
Consolidated Net IncomeConsol Net Inc.
-1.67M-1.05M-1.24M-1.00M-1.08M-0.67M-0.68M-0.78M-0.80M-0.71M-0.60M-0.50M-0.85M-1.01M-2.40M-1.16M-1.85M-1.32M-1.17M-0.99M
Income towards Parent CompanyParent Net Inc
-1.58M-1.05M-1.24M-1.03M-1.08M-0.71M-0.73M-0.83M-0.84M-0.78M-0.66M-0.50M-0.85M-1.01M-2.37M-1.14M-1.81M-1.31M-1.17M-0.98M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-1.58M-1.05M-1.24M-1.03M-1.08M-0.71M-0.73M-0.83M-0.84M-0.78M-0.66M-0.50M-0.85M-1.01M-2.37M-1.14M-1.81M-1.31M-1.17M-0.98M
Additional items
EPS (Basic)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.010.000.000.000.000.00
EPS (Diluted)
0.000.000.000.000.000.000.000.000.000.00-0.010.000.000.000.000.00
Shares Outstanding
403.63M409.96M408.22M419.45M419.45M419.49M419.47M419.50M419.50M419.52M419.51M419.52M419.52M419.91M419.81M420.28M420.28M420.28M420.28M420.28M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
419.45M419.49M419.47M419.50M419.50M419.52M419.51M419.52M419.52M419.91M419.81M420.28M420.28M420.28M420.28M420.28M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
404.01M419.45M419.45M419.45M419.50M419.55M419.50M419.50M419.52M419.52M419.52M419.52M419.91M420.28M420.28M420.28M420.28M420.28M420.28M420.28M
EBITDA
-1.22M-1.04M-1.22M-1.00M-1.08M-0.66M-0.68M-0.78M-0.80M-0.71M-0.60M-0.45M-0.79M-0.95M-2.33M-1.10M-1.80M-1.28M-1.12M
Interest ExpensesInt Expense
0.45M0.00M0.02M0.05M0.05M

Provectus Biopharmaceuticals Income Statement API

Pull Provectus Biopharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PVCT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY